314 related articles for article (PubMed ID: 26563366)
1. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.
Chan DW; Yu SY; Chiu PM; Yao KM; Liu VW; Cheung AN; Ngan HY
J Pathol; 2008 Jul; 215(3):245-52. PubMed ID: 18464245
[TBL] [Abstract][Full Text] [Related]
3. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
4. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.
Pinheiro C; Garcia EA; Morais-Santos F; Scapulatempo-Neto C; Mafra A; Steenbergen RD; Boccardo E; Villa LL; Baltazar F; Longatto-Filho A
BMC Cancer; 2014 Oct; 14():751. PubMed ID: 25296855
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
6. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
[TBL] [Abstract][Full Text] [Related]
8. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
Dong SM; Kim HS; Rha SH; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
[TBL] [Abstract][Full Text] [Related]
10. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
[TBL] [Abstract][Full Text] [Related]
13. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
14. Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation.
Zheng CH; Quan Y; Li YY; Deng WG; Shao WJ; Fu Y
Asian Pac J Cancer Prev; 2014; 15(4):1589-95. PubMed ID: 24641373
[TBL] [Abstract][Full Text] [Related]
15. Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma.
Kim YW; Bae SM; Kim YW; Park DC; Lee KH; Liu HB; Kim IW; Jang CK; Ahn WS
Int J Oncol; 2013 Aug; 43(2):539-47. PubMed ID: 23707988
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
17. [Membrane type 1 matrix metalloproteinase (MT1-MMP) and the regulators of its activity as invasive factors in squamous cell cervical carcinomas].
Timoshenko OS; Gureeva TA; Kugaevskaia EV; Solov'eva NI
Biomed Khim; 2014; 60(6):683-8. PubMed ID: 25552509
[TBL] [Abstract][Full Text] [Related]
18. Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix.
Epstein E; Di Legge A; Måsbäck A; Lindqvist PG; Kannisto P; Testa AC
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):512-6. PubMed ID: 20336641
[TBL] [Abstract][Full Text] [Related]
19. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
20. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
